In comparison with MET inhibitors that targeted MET activation, MET-CAR-T cells recognized and eliminated HCC cells based on overall MET expression, with their activity being unrelated to MET signaling pathway activation (66). The gene discussed is MET; the disease is hepatocellular carcinoma.